Tag: In Situ Hybridization Market – Global In Situ Hybridization Industry Size

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

In Situ Hybridization Market Size Forecast: How Big Could The Market Get By 2030?

The market for in situ hybridization has experienced swift expansion over recent years. Its trajectory indicates an increase from $1.81 billion in 2025 to $2.01 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.8%. This historical growth is traceable to several factors, including the widening scope of molecular pathology research, a heightened demand for cancer diagnostics, the proliferation of cytogenetic testing applications, the presence of sophisticated laboratory infrastructure, and the growing uptake of FISH techniques.

The in situ hybridization market is projected to experience swift expansion in the coming years. This market is forecast to reach $3.08 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.3%. This anticipated growth is driven by several factors, including the escalating demand for personalized medicine diagnostics, the increasing incorporation of AI-powered image analysis, the widening scope of companion diagnostics applications, rising investments in genomic research, and the expanded application of in situ hybridization in detecting infectious diseases. Key trends anticipated during this period encompass the greater adoption of fluorescence-based hybridization methods, a heightened need for precision in molecular diagnostics, the increasing deployment of automated imaging and analysis platforms, the broadening of cancer diagnostic uses, and improved integration of digital pathology solutions.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=67614143&type=smp&name=In-Situ%20Hybridization%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

In Situ Hybridization Market Expansion Drivers: What’s Shaping Future Growth?

The projected expansion of the in-situ hybridization market is anticipated to be driven by a rise in infectious diseases. These illnesses are characterized by their transmission between people through contaminated food and drinks, or via pathogens including viruses, bacteria, fungi, and parasites. In situ hybridization (ISH) utilizes labeled nucleic acid sequences (probes) specific to an infectious organism to identify complementary nucleic acid sequences in tissue. This process, therefore, sees its market growth boosted by the rise in infectious diseases. As an illustration, data from the US government agency, the Centers for Disease Control and Prevention, revealed in March 2024 that tuberculosis cases climbed from 8,320 in 2022 to 9,615 in 2023, representing an increment of 1,295 cases. Consequently, the growing prevalence of infectious diseases is propelling the expansion of the in-situ hybridization market.

In Situ Hybridization Market Segment Landscape And Growth Outlook

The in situ hybridization market covered in this report is segmented –

1) By Product: Analytical Instruments, Kits and Reagents, Software and Services

2) By Technique: Fluorescence In Situ Hybridization (FISH), Chromogenic In Situ Hybridization (CISH)

3) By Probe: Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA)

4) By Application: Cancer, Cytogenetics, Developmental Biology, Infectious Diseases

5) By End Use: Research And Diagnostic Laboratories, Contract Research Organization (CROs), Academic Institutes

Subsegments:

1) By Analytical Instruments: Fluorescence Microscopes, Imaging Systems, Hybridization Systems

2) By Kits and Reagents: Hybridization Kits, Detection Kits, Probes And Reagents

3) By Software and Services: Image Analysis Software, Data Management Software, Consulting And Support Services

In Situ Hybridization Market Strategic Trends: What Defines The Next Growth Phase?

Leading companies in the in situ hybridization market are concentrating on innovative product solutions, such as HCR RNA-CISH (Hybridization Chain Reaction RNA Chromogenic in situ Hybridization), to enhance their profitability within the market. Hybridization Chain Reaction RNA Chromogenic in situ Hybridization is defined as a technique that facilitates the visualization of RNA molecules in cells and tissues with high resolution and sensitivity. For example, in February 2023, Molecular Instruments (MI), a biotech spinout from the California Institute of Technology, introduced HCR RNA-CISH to improve automated chromogenic in situ hybridization (ISH) workflows that rely on RNAscope. The HCR RNA-CISH kits offer superior performance compared to any existing chromogenic in situ hybridization approach, even with double the turnaround time and half the cost. Furthermore, it features native support for IHC (Immunohistochemistry) codetection and full compatibility with all major automation platforms.

In Situ Hybridization Market Competitive Analysis Of Leading Industry Participants

Major companies operating in the in situ hybridization market are Thermo Fisher Scientific Inc., Bio SB Inc., BioGenex Laboratories, Advanced Cell Diagnostics Inc., Exiqon A/S, Agilent Technologies Inc., F. Hoffmann-La Roche AG, Abbott Laboratories Inc., Merck KGaA, PerkinElmer Inc., Biocare Medical LLC, Genemed Biotechnologies, Danaher Corporation, Leica Biosystems Nussloch GmbH, Bio-Rad Laboratories Inc., Oxford Gene Technology, Qiagen, Bio-Techne Corporation, Cytocell Ltd., Enzo Life Sciences Inc., Eurofins Scientific SE, Zytomed System GmbH, Akoya Biosciences Inc., Becton Dickinson and Company (BD), DAKO Systemtechnik und Service GmbH & Co, NanoString Technologies Inc., Visiopharm A/S

View The Full In Situ Hybridization Market Report:

https://thebusinessresearchcompany.com/report/in-situ-hybridization-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

In Situ Hybridization Market Geographic Spread And Regional Opportunities

North America was the largest region in the in situ hybridization market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global in situ hybridization market during the forecast period. The regions covered in the in situ hybridization market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Value Of The In Situ Hybridization Market Increase Between 2026 And 2030?

The market for in situ hybridization has experienced swift expansion recently. This market is projected to expand from $1.81 billion in 2025 to $2.01 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.8%. Historically, this growth has been driven by factors such as the broadening of molecular pathology research, a rise in demand for cancer diagnostics, the proliferation of cytogenetic testing applications, the accessibility of sophisticated laboratory infrastructure, and the increasing embrace of FISH techniques.

The in situ hybridization market is projected to experience substantial growth in the coming years. It is forecast to expand to $3.08 billion by 2030, achieving an 11.3% compound annual growth rate (CAGR). This growth during the forecast period is propelled by factors such as the increasing demand for personalized medicine diagnostics, the rising integration of AI-based image analysis, the expansion of companion diagnostics applications, growing investments in genomic research, and the increased application of in situ hybridization in infectious disease detection. Prominent trends expected during this forecast period encompass the increasing adoption of fluorescence-based hybridization techniques, a heightened demand for molecular diagnostic accuracy, the growing utilization of automated imaging and analysis systems, the expansion of cancer diagnostic applications, and the enhanced integration of digital pathology tools.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24571&type=smp

Which Drivers Are Advancing The In Situ Hybridization Market Growth?

The in-situ hybridization market is anticipated to expand due to the rising incidence of infectious diseases. These diseases are characterized by their transmission between people, often through contaminated food and drink, or via agents like viruses, bacteria, fungi, and parasites. In situ hybridization (ISH) functions by employing specific labeled nucleic acid sequences (probes) to locate complementary nucleic acid sequences within tissue, thereby aiding in the identification of infectious organisms. Consequently, the surge in infectious diseases is stimulating the growth of the in-situ hybridization market. For example, data released in March 2024 by the Centers for Disease Control and Prevention, a US government agency, indicated a rise in tuberculosis cases from 8,320 in 2022 to 9,615 in 2023, representing an increase of 1,295 cases. This demonstrates that the expansion of infectious diseases is a key factor propelling the in-situ hybridization market forward.

What Segment Categories Are Evaluated In The In Situ Hybridization Market Study?

The in situ hybridization market covered in this report is segmented –

1) By Product: Analytical Instruments, Kits and Reagents, Software and Services

2) By Technique: Fluorescence In Situ Hybridization (FISH), Chromogenic In Situ Hybridization (CISH)

3) By Probe: Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA)

4) By Application: Cancer, Cytogenetics, Developmental Biology, Infectious Diseases

5) By End Use: Research And Diagnostic Laboratories, Contract Research Organization (CROs), Academic Institutes

Subsegments:

1) By Analytical Instruments: Fluorescence Microscopes, Imaging Systems, Hybridization Systems

2) By Kits and Reagents: Hybridization Kits, Detection Kits, Probes And Reagents

3) By Software and Services: Image Analysis Software, Data Management Software, Consulting And Support Services

What Trends Are Shaping The In Situ Hybridization Market Structure?

Leading companies in the in situ hybridization market are prioritizing innovative product solutions, such as HCR RNA-CISH (Hybridization Chain Reaction RNA Chromogenic in situ Hybridization), to increase their market profitability. Hybridization chain Reaction RNA chromogenic in situ hybridization describes a technique that facilitates the visualization of RNA molecules within cells and tissues with high resolution and sensitivity. For instance, in February 2023, Molecular Instruments (MI), a biotech spinout from the California Institute of Technology, launched HCR RNA-CISH to enhance automated chromogenic in situ hybridization (ISH) workflows that rely on RNAscope. The HCR RNA-CISH kits offer superior performance compared to any existing chromogenic in situ hybridization approach, featuring double the turnaround time and half the cost. It also includes native support for IHC (Immunohistochemistry) codetection and full compatibility with all major automation platforms.

Which Key Players Are Active In The In Situ Hybridization Market?

Major companies operating in the in situ hybridization market are Thermo Fisher Scientific Inc., Bio SB Inc., BioGenex Laboratories, Advanced Cell Diagnostics Inc., Exiqon A/S, Agilent Technologies Inc., F. Hoffmann-La Roche AG, Abbott Laboratories Inc., Merck KGaA, PerkinElmer Inc., Biocare Medical LLC, Genemed Biotechnologies, Danaher Corporation, Leica Biosystems Nussloch GmbH, Bio-Rad Laboratories Inc., Oxford Gene Technology, Qiagen, Bio-Techne Corporation, Cytocell Ltd., Enzo Life Sciences Inc., Eurofins Scientific SE, Zytomed System GmbH, Akoya Biosciences Inc., Becton Dickinson and Company (BD), DAKO Systemtechnik und Service GmbH & Co, NanoString Technologies Inc., Visiopharm A/S

Access The Complete In Situ Hybridization Market Report:

https://www.thebusinessresearchcompany.com/report/in-situ-hybridization-global-market-report

Which Geographic Region Represents The Largest In Situ Hybridization Market Share?

North America was the largest region in the in situ hybridization market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global in situ hybridization market during the forecast period. The regions covered in the in situ hybridization market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a In Situ Hybridization Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/in-situ-hybridization-global-market-report

Browse Through More Reports Similar to the Global In Situ Hybridization Market 2026, By The Business Research Company

Hybrid Seeds Market Report 2026

https://www.thebusinessresearchcompany.com/report/hybrid-seeds-global-market-report

Biocomposites Market Report 2026

https://www.thebusinessresearchcompany.com/report/biocomposites-global-market-report

Hybrid Cloud Market Report 2026

https://www.thebusinessresearchcompany.com/report/hybrid-cloud-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, What Market Size Is The In Situ Hybridization Market Expected To Reach Based On Its 2026 Value?

The in situ hybridization market size has experienced rapid growth in recent years. It is forecast to expand from $1.81 billion in 2025 to $2.01 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.8%. The historical increase can be attributed to the broadening of molecular pathology research, a rising demand for cancer diagnostics, the expansion of cytogenetic testing applications, the availability of advanced laboratory infrastructure, and the increasing adoption of FISH techniques.

The in situ hybridization market is projected to undergo significant expansion in the upcoming years, with its valuation expected to reach $3.08 billion by 2030, reflecting an impressive compound annual growth rate (CAGR) of 11.3%. This anticipated growth throughout the forecast period is primarily driven by factors such as the increasing demand for personalized medicine diagnostics, the rising integration of AI-based image analysis, the expansion of companion diagnostics applications, growing investments in genomic research, and the increasing use of in situ hybridization in infectious disease detection. Key trends during this period are expected to include the increasing adoption of fluorescence-based hybridization techniques, a rising demand for molecular diagnostic accuracy, the growing use of automated imaging and analysis systems, the expansion of cancer diagnostic applications, and enhanced integration of digital pathology tools.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24571&type=smp

Which Key Drivers Are Affecting The In Situ Hybridization Market Development?

The in-situ hybridization market is anticipated to expand moving forward, primarily fueled by the growing number of infectious diseases. These diseases are defined as conditions that spread between individuals via tainted food and beverages, as well as through pathogens like viruses, bacteria, fungi, and parasites. In situ hybridization (ISH) works by utilizing labeled nucleic acid sequences, known as probes, specific to an infectious organism to detect complementary nucleic acid sequences present in tissue. Therefore, the increase in infectious diseases directly boosts the development of the in-situ hybridization market. For instance, in March 2024, the Centers for Disease Control and Prevention, a US-based government agency, reported that tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023, an increase of 1,295 cases. This ongoing rise in infectious diseases is a significant factor propelling the growth of the in-situ hybridization market.

Which Segment Types Are Examined In The In Situ Hybridization Market Segment Study?

The in situ hybridization market covered in this report is segmented –

1) By Product: Analytical Instruments, Kits and Reagents, Software and Services

2) By Technique: Fluorescence In Situ Hybridization (FISH), Chromogenic In Situ Hybridization (CISH)

3) By Probe: Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA)

4) By Application: Cancer, Cytogenetics, Developmental Biology, Infectious Diseases

5) By End Use: Research And Diagnostic Laboratories, Contract Research Organization (CROs), Academic Institutes

Subsegments:

1) By Analytical Instruments: Fluorescence Microscopes, Imaging Systems, Hybridization Systems

2) By Kits and Reagents: Hybridization Kits, Detection Kits, Probes And Reagents

3) By Software and Services: Image Analysis Software, Data Management Software, Consulting And Support Services

What Trends Are Transforming The In Situ Hybridization Market?

Companies active in the in situ hybridization market are concentrating on inventive product offerings, including HCR RNA-CISH (Hybridization Chain Reaction RNA Chromogenic in situ Hybridization), to boost their market profitability. Hybridization chain Reaction RNA chromogenic in situ hybridization is defined as a method facilitating the visualization of RNA molecules within cells and tissues, characterized by high resolution and sensitivity. As an illustration, Molecular Instruments (MI), a biotech entity originating from the California Institute of Technology, introduced HCR RNA-CISH in February 2023. This launch aimed to improve automated chromogenic in situ hybridization (ISH) workflows that rely on RNAscope. These HCR RNA-CISH kits deliver superior performance compared to current chromogenic in situ hybridization methods, offering double the turnaround time and half the cost. Additionally, the solution includes inherent support for IHC (Immunohistochemistry) codetection and comprehensive compatibility across all leading automation platforms.

Which Players Are Part Of The Competitive Landscape Of The In Situ Hybridization Market?

Major companies operating in the in situ hybridization market are Thermo Fisher Scientific Inc., Bio SB Inc., BioGenex Laboratories, Advanced Cell Diagnostics Inc., Exiqon A/S, Agilent Technologies Inc., F. Hoffmann-La Roche AG, Abbott Laboratories Inc., Merck KGaA, PerkinElmer Inc., Biocare Medical LLC, Genemed Biotechnologies, Danaher Corporation, Leica Biosystems Nussloch GmbH, Bio-Rad Laboratories Inc., Oxford Gene Technology, Qiagen, Bio-Techne Corporation, Cytocell Ltd., Enzo Life Sciences Inc., Eurofins Scientific SE, Zytomed System GmbH, Akoya Biosciences Inc., Becton Dickinson and Company (BD), DAKO Systemtechnik und Service GmbH & Co, NanoString Technologies Inc., Visiopharm A/S

Get The Full In Situ Hybridization Market Report:

https://www.thebusinessresearchcompany.com/report/in-situ-hybridization-global-market-report

Which Region Represents The Largest Share Of The In Situ Hybridization Market?

North America was the largest region in the in situ hybridization market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global in situ hybridization market during the forecast period. The regions covered in the in situ hybridization market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized In Situ Hybridization Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=24571&type=smp

Browse Through More Reports Similar to the Global In Situ Hybridization Market 2026, By The Business Research Company

Hybrid Seeds Market Report 2026

https://www.thebusinessresearchcompany.com/report/hybrid-seeds-global-market-report

Biocomposites Market Report 2026

https://www.thebusinessresearchcompany.com/report/biocomposites-global-market-report

Hybrid Cloud Market Report 2026

https://www.thebusinessresearchcompany.com/report/hybrid-cloud-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The In Situ Hybridization Market Evolve From 2026 To 2030?

The in situ hybridization market size has observed swift growth over recent years. Forecasts indicate it will expand from $1.81 billion in 2025 to $2.01 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.8%. This historical period’s growth can be attributed to the broadening of molecular pathology research, increasing demand for cancer diagnostics, the expansion of cytogenetic testing applications, the availability of advanced laboratory infrastructure, and the rising adoption of FISH techniques.

The in situ hybridization market is expected to experience substantial growth in the upcoming years. It is projected to reach $3.08 billion in 2030, showing a compound annual growth rate (CAGR) of 11.3%. This expansion during the forecast period is attributed to factors such as the increasing demand for personalized medicine diagnostics, the rising integration of AI-based image analysis, the broadening of companion diagnostics applications, growing investments in genomic research, and the increasing use of in situ hybridization in infectious disease detection. Significant trends anticipated for the forecast period include the increasing adoption of fluorescence-based hybridization techniques, a rising demand for molecular diagnostic accuracy, the growing use of automated imaging and analysis systems, the expansion of cancer diagnostic applications, and the enhanced integration of digital pathology tools.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24571&type=smp

What Drivers Are Influencing The In Situ Hybridization Market?

The in-situ hybridization market is expected to grow due to the increasing incidence of infectious diseases. Infectious diseases are conditions that can be transmitted from one person to another through contaminated food and beverages or via pathogens like viruses, bacteria, fungi, and parasites. In situ hybridization (ISH) helps identify specific complementary nucleic acid sequences present in tissue by using labeled nucleic acid sequences (probes) unique to the infectious organism, therefore, a rise in infectious diseases stimulates the expansion of the in-situ hybridization market. For instance, the Centers for Disease Control and Prevention, a US-based government agency, reported in March 2024 that tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, which is an increase of 1,295 cases. Consequently, the growing number of infectious diseases is driving the growth of the in-situ hybridization market.

Which Segment Areas Are Covered In The In Situ Hybridization Market Analysis?

The in situ hybridization market covered in this report is segmented –

1) By Product: Analytical Instruments, Kits and Reagents, Software and Services

2) By Technique: Fluorescence In Situ Hybridization (FISH), Chromogenic In Situ Hybridization (CISH)

3) By Probe: Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA)

4) By Application: Cancer, Cytogenetics, Developmental Biology, Infectious Diseases

5) By End Use: Research And Diagnostic Laboratories, Contract Research Organization (CROs), Academic Institutes

Subsegments:

1) By Analytical Instruments: Fluorescence Microscopes, Imaging Systems, Hybridization Systems

2) By Kits and Reagents: Hybridization Kits, Detection Kits, Probes And Reagents

3) By Software and Services: Image Analysis Software, Data Management Software, Consulting And Support Services

What Key Developments And Trends Are Impacting The In Situ Hybridization Market?

Major companies in the in situ hybridization market are concentrating on advanced product solutions such as HCR RNA-CISH (Hybridization Chain Reaction RNA Chromogenic in situ Hybridization) to enhance their profitability. Hybridization Chain Reaction RNA Chromogenic in situ Hybridization is a technique that enables the visualization of RNA molecules in cells and tissues with high resolution and sensitivity. For example, in February 2023, Molecular Instruments (MI), a biotech spinout from the California Institute of Technology, launched HCR RNA-CISH to improve automated chromogenic in situ hybridization (ISH) workflows that rely on RNAscope. The HCR RNA-CISH kits offer superior performance compared to existing chromogenic in situ hybridization methods, providing double the turnaround time and half the cost. It also features native support for IHC (Immunohistochemistry) codetection and complete compatibility with all major automation platforms.

Which Global Companies Are Actively Competing In The In Situ Hybridization Market?

Major companies operating in the in situ hybridization market are Thermo Fisher Scientific Inc., Bio SB Inc., BioGenex Laboratories, Advanced Cell Diagnostics Inc., Exiqon A/S, Agilent Technologies Inc., F. Hoffmann-La Roche AG, Abbott Laboratories Inc., Merck KGaA, PerkinElmer Inc., Biocare Medical LLC, Genemed Biotechnologies, Danaher Corporation, Leica Biosystems Nussloch GmbH, Bio-Rad Laboratories Inc., Oxford Gene Technology, Qiagen, Bio-Techne Corporation, Cytocell Ltd., Enzo Life Sciences Inc., Eurofins Scientific SE, Zytomed System GmbH, Akoya Biosciences Inc., Becton Dickinson and Company (BD), DAKO Systemtechnik und Service GmbH & Co, NanoString Technologies Inc., Visiopharm A/S

Read the full in situ hybridization market report here:

https://www.thebusinessresearchcompany.com/report/in-situ-hybridization-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The In Situ Hybridization Market?

North America was the largest region in the in situ hybridization market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global in situ hybridization market during the forecast period. The regions covered in the in situ hybridization market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored In Situ Hybridization Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24571&type=smp

Browse Through More Reports Similar to the Global In Situ Hybridization Market 2026, By The Business Research Company

Hybrid Seeds Market Report 2026

https://www.thebusinessresearchcompany.com/report/hybrid-seeds-global-market-report

Biocomposites Market Report 2026

https://www.thebusinessresearchcompany.com/report/biocomposites-global-market-report

Hybrid Cloud Market Report 2026

https://www.thebusinessresearchcompany.com/report/hybrid-cloud-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the In Situ Hybridization Market between 2026 and 2030?

The in situ hybridization market has seen swift expansion in recent years. It is projected to climb from $1.81 billion in 2025 to $2.01 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.8%. Historically, this growth has been driven by factors such as the broader scope of molecular pathology research, a rising need for cancer diagnostics, the development of cytogenetic testing applications, the availability of advanced laboratory infrastructure, and the increasing adoption of FISH techniques.

The in situ hybridization market is expected to experience substantial growth in the upcoming years, with its size projected to reach $3.08 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.3%. This expansion during the forecast period can be attributed to the increasing demand for personalized medicine diagnostics, the rising integration of AI-based image analysis, the broadening of companion diagnostics applications, growing investments in genomic research, and the expanding use of in situ hybridization in infectious disease detection. Key trends for the forecast period include the increasing adoption of fluorescence-based hybridization techniques, a rising demand for molecular diagnostic accuracy, the growing use of automated imaging and analysis systems, the expansion of cancer diagnostic applications, and enhanced integration of digital pathology tools.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24571&type=smp

Which Drivers Are Expected To Impact The In Situ Hybridization Market During The Forecast Period?

The in-situ hybridization market is projected to expand due to an increase in infectious diseases. These conditions are illnesses transmitted between individuals via contaminated food and beverages or through pathogens such as viruses, bacteria, fungi, and parasites. In situ hybridization (ISH) aims to identify complementary nucleic acid sequences within tissue by employing labeled nucleic acid sequences (probes) specific to the infectious organism, thereby boosting the growth of the in-situ hybridization market as infectious diseases rise. For instance, in March 2024, the Centers for Disease Control and Prevention, a US-based government agency, reported that tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, marking a rise of 1,295 cases. Consequently, the growing prevalence of infectious diseases is stimulating the growth of the in-situ hybridization market.

Which Segments Are Driving Activity In The In Situ Hybridization Market?

The in situ hybridization market covered in this report is segmented –

1) By Product: Analytical Instruments, Kits and Reagents, Software and Services

2) By Technique: Fluorescence In Situ Hybridization (FISH), Chromogenic In Situ Hybridization (CISH)

3) By Probe: Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA)

4) By Application: Cancer, Cytogenetics, Developmental Biology, Infectious Diseases

5) By End Use: Research And Diagnostic Laboratories, Contract Research Organization (CROs), Academic Institutes

Subsegments:

1) By Analytical Instruments: Fluorescence Microscopes, Imaging Systems, Hybridization Systems

2) By Kits and Reagents: Hybridization Kits, Detection Kits, Probes And Reagents

3) By Software and Services: Image Analysis Software, Data Management Software, Consulting And Support Services

What Trends Are Expected To Impact The Competitive Landscape Of The In Situ Hybridization Market?

Major companies operating in the in situ hybridization market are prioritizing innovative product solutions, such as HCR RNA-CISH (Hybridization Chain Reaction RNA Chromogenic in situ Hybridization), to enhance their profitability within the market. Hybridization Chain Reaction RNA chromogenic in situ hybridization is a methodology that enables the visualization of RNA molecules in cells and tissues with advanced resolution and sensitivity. For instance, in February 2023, Molecular Instruments (MI), a biotech spinout from the California Institute of Technology, introduced HCR RNA-CISH to optimize automated chromogenic in situ hybridization (ISH) workflows that utilize RNAscope. The HCR RNA-CISH kits deliver improved performance over existing chromogenic in situ hybridization approaches, offering double the turnaround time and half the cost. It also incorporates native support for IHC (Immunohistochemistry) codetection and ensures complete compatibility with all major automation platforms.

Which Major Firms Are Strengthening Their Position In The In Situ Hybridization Market?

Major companies operating in the in situ hybridization market are Thermo Fisher Scientific Inc., Bio SB Inc., BioGenex Laboratories, Advanced Cell Diagnostics Inc., Exiqon A/S, Agilent Technologies Inc., F. Hoffmann-La Roche AG, Abbott Laboratories Inc., Merck KGaA, PerkinElmer Inc., Biocare Medical LLC, Genemed Biotechnologies, Danaher Corporation, Leica Biosystems Nussloch GmbH, Bio-Rad Laboratories Inc., Oxford Gene Technology, Qiagen, Bio-Techne Corporation, Cytocell Ltd., Enzo Life Sciences Inc., Eurofins Scientific SE, Zytomed System GmbH, Akoya Biosciences Inc., Becton Dickinson and Company (BD), DAKO Systemtechnik und Service GmbH & Co, NanoString Technologies Inc., Visiopharm A/S

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/in-situ-hybridization-global-market-report

Which Regions Are Poised For Strategic Growth In The In Situ Hybridization Market?

North America was the largest region in the in situ hybridization market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global in situ hybridization market during the forecast period. The regions covered in the in situ hybridization market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized In Situ Hybridization Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24571&type=smp

Browse Through More Reports Similar to the Global In Situ Hybridization Market 2026, By The Business Research Company

Hybrid Seeds Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hybrid-seeds-global-market-report

Biocomposites Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/biocomposites-global-market-report

Hybrid Cloud Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hybrid-cloud-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company